Patents by Inventor Monika A. Niewczas

Monika A. Niewczas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11885813
    Abstract: This disclosure relates to methods of diagnosing and predicting renal disease, using one, two, or more biomarkers, including sTN-FR1, sTNFR2, sFAS, TNF, and IL-6.
    Type: Grant
    Filed: November 1, 2019
    Date of Patent: January 30, 2024
    Assignee: Joslin Diabetes Center, Inc.
    Inventors: Monika A Niewczas, Andrzej S. Krolewski
  • Publication number: 20200072849
    Abstract: This disclosure relates to methods of diagnosing and predicting renal disease, using one, two, or more biomarkers, including sTN-FR1, sTNFR2, sFAS, TNF, and IL-6.
    Type: Application
    Filed: November 1, 2019
    Publication date: March 5, 2020
    Applicant: Joslin Diabetes Center, Inc.
    Inventors: Monika A. Niewczas, Andrzej S. Krolewski
  • Patent number: 10488420
    Abstract: This disclosure relates to methods of diagnosing and predicting renal disease, using one, two, or more biomarkers, including sTN-FR1, sTNFR2, sFAS, TNF, and IL-6.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: November 26, 2019
    Assignee: Joslin Diabetes Center, Inc.
    Inventors: Monika A. Niewczas, Andrzej S. Krolewski
  • Publication number: 20180011109
    Abstract: This disclosure relates to methods of diagnosing and predicting renal disease, using one, two, or more biomarkers, including sTN-FR1, sTNFR2, sFAS, TNF, and IL-6.
    Type: Application
    Filed: September 21, 2017
    Publication date: January 11, 2018
    Applicant: Joslin Diabetes Center, Inc.
    Inventors: Monika A. Niewczas, Andrzej S. Krolewski
  • Publication number: 20180003721
    Abstract: The present invention relates to biomarkers that are predictive of renal disease in patients who have diabetes. The present invention also provides methods of using such biomarkers to predict the risk that a diabetic patient will develop renal disease, and/or to identify a patient who has diabetes as being in need of a therapy to prevent or delay the onset of a renal disease.
    Type: Application
    Filed: January 15, 2016
    Publication date: January 4, 2018
    Applicant: Joslin Diabetes Center
    Inventors: Monika A. Niewczas, Andrzej S. Krolewski
  • Patent number: 9791452
    Abstract: This disclosure relates to methods of diagnosing and predicting renal disease, using one, two, or more biomarkers, including sTNFR1, sTNFR2, sFAS, TNF, and IL-6.
    Type: Grant
    Filed: December 9, 2009
    Date of Patent: October 17, 2017
    Assignee: Joslin Diabetes Center, Inc.
    Inventors: Monika A. Niewczas, Andrzej S. Krolewski
  • Publication number: 20110281758
    Abstract: This disclosure relates to methods of diagnosing and predicting renal disease, using one, two, or more biomarkers, including sTNFR1, sTNFR2, sFAS, TNF, and IL-6.
    Type: Application
    Filed: December 9, 2009
    Publication date: November 17, 2011
    Applicant: JOSLIN DIABETES CENTER, INC.
    Inventors: Monika A. Niewczas, Andrzej S. Krolewski